What is the recommended treatment for dilantin-induced gingival hyperplasia?

Gingival hyperplasia caused by Dilantin (phenytoin) is characterized by the overgrowth of gum tissue, often requiring intervention to manage both aesthetic and functional issues. The recommended treatment is a gingivectomy, which involves the surgical removal of the excessive gum tissue. This procedure not only alleviates the physical symptoms associated with the hyperplasia but also helps improve oral hygiene by allowing better access to the teeth for cleaning.

Scaling and root planing, while useful for treating periodontal disease, primarily involves cleaning the teeth and would not adequately address the tissue overgrowth associated with hyperplasia. Antibiotics are not an appropriate treatment for gingival hyperplasia since it is not caused by an infection, and the condition typically does not respond to antibiotic therapy. Topical corticosteroids, while useful in reducing inflammation, would not effectively eliminate the excess gum tissue associated with Dilantin-induced hyperplasia.

Thus, a gingivectomy is the most effective option to correct the condition and restore healthy gum architecture.